Unlike Pfizer Moderna can meet 2023 COVID forecast analysts say Reuterscom

Nov 1(Reuters) – Moderna (MRNA.O) should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to reach that goal, a… [+2794 chars]Read More